trimethoprim--sulfamethoxazole-drug-combination has been researched along with nitazoxanide* in 3 studies
1 review(s) available for trimethoprim--sulfamethoxazole-drug-combination and nitazoxanide
Article | Year |
---|---|
Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.
Topics: Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Drug Resistance, Microbial; Humans; Metronidazole; Nitro Compounds; Nitrofurantoin; Rifamycins; Rifaximin; Thiazoles; Tinidazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
1 trial(s) available for trimethoprim--sulfamethoxazole-drug-combination and nitazoxanide
Article | Year |
---|---|
Cryptosporidiosis in Benha, study of some recent modalities in diagnosis and treatment.
A total prevalence of cryptosporidiosis was carried out on 1087 diarrheal patients of all age groups attending the outpatient clinics using modified Ziehl-Neelsen stain (MZN) and Meriflour direct immunofluorescent technique (IFA). IFA was more sensitive, specific and gave positive results 19.5% than MZN stain which gave a positivity 13.5% Cases were divided into 3 groups, each group was treated by one of nitazoxanid (NTZ), or co-trimoxazole or placebo. The most effective drug was NTZ which cured 39 patients (79.6%) out of 49 patients followed by co-trimoxazole that gave cure of 20 (41.6%) out of 48 patients. Placebo cured 20 (40%) out of 50 patients. Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Cryptosporidiosis; Diarrhea; Egypt; Female; Fluorescent Antibody Technique, Direct; Humans; Infant; Male; Nitro Compounds; Prevalence; Sensitivity and Specificity; Thiazoles; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
1 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and nitazoxanide
Article | Year |
---|---|
Case report: Nitazoxanide treatment failure in chronic isosporiasis.
We report a 60-year-old immunocompetent patient with chronic biliary isosporiasis who failed to respond to orally administered cotrimoxazole prophylaxis and orally administered treatment with nitazoxanide, a 5-nitrothiazole benzamide compound. Severe malabsorption was regarded as responsible for the subtherapeutic levels of nitazoxanide in plasma and bile, resulting in treatment failure. Intravenously administered cotrimoxazole stopped the shedding of Isospora belli oocysts in bile within 5 days, excluding initially suspected resistance to cotrimoxazole. Patients with malabsorption and cholangitis due to Coccidia such as Isospora belli and Cryptosporidium spp. or due to protozoa that cause microsporidiasis seem to be predisposed to fail to respond to otherwise effective treatment. Topics: Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Bile; Chronic Disease; Humans; Immunocompetence; Injections, Intravenous; Isospora; Isosporiasis; Male; Middle Aged; Nitro Compounds; Thiazoles; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |